Farallon Capital Management LLC Bristol Myers Squibb CO Transaction History

Farallon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $202 Million - $229 Million	-3,500,000 Reduced 93.33%	250,000 $15.5 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $7.18 Million - $7.96 Million	125,000 Added 3.45%	3,750,000 $226 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $199 Million - $232 Million	3,625,000 New	3,625,000 $213 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $71.5 Million - $82.3 Million	-1,192,500 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $9.74 Million - $10.6 Million	-162,500 Reduced 11.99%	1,192,500 $73.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $74.8 Million - $86.4 Million	1,355,000	1,355,000 $86.4 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.